BLOOD TEST FOR DETECTION OF PANCREATIC CANCER
Background: Pancreatic cancer kills ~30,000 patients a year. Most patients die ~1 year after diagnosis despite aggressive therapy. The problem is that most patients are diagnosed at late stage disease and are therefore not candidates for surgical intervention (resection). As such there is an urgent need for blood tests which can diagnose cancer early when treatment can be more effective.
Pancreatic cancer market.
Ø Fifth leading cause of cancer death in US (1st is heart disease)
Ø Five year survival rate of <4%.
Ø Cost of pancreatic cancer industry is $1 billion is USA
Ø No current early detection blood test available
Clinical Data: This new blood test has been tested on pancreatic cancer patients (confirmed by biopsy) and was significantly elevated compared with healthy controls.
IP: patents are being filed for testing methodology and disease application.
Background: Pancreatic cancer kills ~30,000 patients a year. Most patients die ~1 year after diagnosis despite aggressive therapy. The problem is that most patients are diagnosed at late stage disease and are therefore not candidates for surgical intervention (resection). As such there is an urgent need for blood tests which can diagnose cancer early when treatment can be more effective.
Pancreatic cancer market.
Ø Fifth leading cause of cancer death in US (1st is heart disease)
Ø Five year survival rate of <4%.
Ø Cost of pancreatic cancer industry is $1 billion is USA
Ø No current early detection blood test available
Clinical Data: This new blood test has been tested on pancreatic cancer patients (confirmed by biopsy) and was significantly elevated compared with healthy controls.
IP: patents are being filed for testing methodology and disease application.
